Zynex, Inc. Agrees to Criminal Resolution Addressing Claims of Millions of Dollars of Health Care Fraud, Securities Fraud and Related Offenses

PROVIDENCE – Zynex, Inc, a Colorado-based medical device company, has agreed to enter into a non-prosecution agreement (NPA) with the U.S. Attorney’s Office for the District of Rhode Island and admit to participating in a conspiracy to commit health care fraud, securities fraud, mail fraud, and other violations, announced United States Attorney Charles C. Calenda. Under the agreement, which is subject to approval of the bankruptcy court in Zynex’s ongoing Chapter 11 proceedings, Zynex will pay between $5 and $12.5 million depending on the company’s earnings and profit over the period of the agreement. Zynex will also forfeit all unpaid claims submitted prior to September 1, 2025, including claims submitted during the period of suspension of TRICARE payments. These forfeited claims include more than $85 million billed to TRICARE during a suspension period and more than $13 million billed to other payors and patients.

Read more on www.justice.gov